Aminopeptidase N:a therapeutic target in human liver cancer stem cells

Zhipeng SUN; Xuejian WANG; Chunyan FANG; Gong DAI; Wenfang XU.
Journal of International Pharmaceutical Research ; (6): 522-526,527, 2014.
Artículo en Zh | WPRIM | ID: wpr-600105

Documentos relacionados

  1. Aminopeptidase N: A therapeutic target in human liver cancer stem cells
  2. A novel aminopeptidase N/CD13 inhibitor selectively targets an endothelial form of CD13 after coupling to proteins.
  3. Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein.
  4. Integration of multiomics analyses reveals unique insights into CD24-mediated immunosuppressive tumor microenvironment of breast cancer.
  5. NGR-Based Radiopharmaceuticals for Angiogenesis Imaging: A Preclinical Review.
  6. A facile turn-on chemiluminescence probe for sensitive imaging on aminopeptidase N activity.
  7. Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.
  8. Proteasomes Are Critical for Maintenance of CD133+CD24+ Kidney Progenitor Cells.
  9. The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma.
  10. CD24 blockade as a novel strategy for cancer treatment.